9 results
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
21 Apr 22
FSD Pharma Inc. 6-K
10:09am
member at Inteligex Inc., a company developing novel stem cell therapies for the treatment of traumatic spinal cord injuries and other diseases
20-F
2021 FY
QNTM
Quantum BioPharma Ltd
31 Mar 22
Annual report (foreign)
8:09am
extensive clinical trials, or as the use of these Product Candidates becomes more widespread if they receive regulatory approval, illnesses, injuries … successfully defend ourselves against claims that our Product Candidates, medicines or other therapeutic applications caused injuries, we could incur
40-F
2020 FY
EX-99.1
QNTM
Quantum BioPharma Ltd
17 Mar 21
Annual report (Canada)
12:00am
becomes more widespread if they receive regulatory approval, illnesses, injuries, discomforts and other adverse events that were observed in earlier trials … cannot successfully defend ourselves against claims that our product candidates or medicines caused injuries, we could incur substantial liabilities
40-F
EX-99.1
oadsa ee1lsmzlax87g
4 Mar 20
Annual report (Canada)
12:29pm
40FR12B
EX-99.39
edoi726 7ygt4vrtynfp
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.47
ka22of22mbkmi5m
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.11
jozqveqpf314q4p
6 Dec 19
Initial registration of securities (Canada)
12:28pm
- Prev
- 1
- Next